A JSC Terminal-led investor consortium to acquire Xantis Pharma Russia from Novator Partners.

Synopsis

A JSC Terminal-led investor consortium to acquire Xantis Pharma Russia, a pharmaceutical sales and marketing company, from Novator Partners, a private equity investment firm. Financial terms were not disclosed.

Principals

target

Xantis Pharma Russia

bidder

Jsc Terminal

Show Details & Financials

Did you work on this deal?

Claim Deal

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Claim Deal

Market Context

MergerLinks - A JSC Terminal-led investor consortium to acquire Xantis Pharma Russia from Novator Partners.